Burgeon Biotechnology

Burgeon Biotechnology is a Turkish biotech company established in 2017 in Ankara, focusing on innovations in medical aesthetics and biostimulation technologies. The company develops minimally invasive products aimed at enhancing and regenerating the skin's natural radiance, providing long-lasting aesthetic transformations. Their product range includes advanced dermal fillers and biostimulants that address signs of aging, such as wrinkles and volume loss. Notable products include Novuma, a mineral-based dermal filler that promotes collagen and elastin production; CALHYDRA, a dual-action dermal filler kit that offers lifting and moisture; and the Youth Support Series, which utilizes Hyaluronic Acid to restore moisture and volume in the skin. Burgeon Biotechnology prioritizes high standards of quality, safety, and efficacy, supported by a dedicated R&D team. The company has expanded its global reach through strategic partnerships, particularly with Laboratoires VIVACY, enhancing its expertise in skin regeneration. Their primary customers are medical professionals and clinics specializing in aesthetic medicine and dermatology.

• Employees33
• Founded2017